Featured Research

from universities, journals, and other organizations

Inclusion of falls history shown to enhance accuracy of fracture risk assessment models

Date:
March 24, 2011
Source:
International Osteoporosis Foundation
Summary:
A new study shows how the inclusion of falls history, in addition to clinical risk factors (CRFs) and bone mineral density (BMD) values, would greatly improve the accuracy of fracture prediction models.

Researchers from the MRC Lifecourse Epidemiology Unit in Southampton, UK, have presented a new study that shows how the inclusion of falls history, in addition to clinical risk factors (CRFs) and bone mineral density (BMD) values, would greatly improve the accuracy of fracture prediction models.

The research findings were presented at the European Congress on Osteoporosis & Osteoarthritis in Valencia, Spain.

Using results from the Hertfordshire Cohort Study, the investigators examined the relative contributions of CRFs, BMD and falls history to fracture prediction. They concluded that fall history is an independent risk factor for fracture. Its inclusion in a fracture prediction model in men (in addition to CRFs and BMD) improved accuracy by 6%. The authors show that such models would have positive predictive values of 21.5% and 29.8% in men and women, respectively.

"These findings are also directly applicable to clinical practice," commented Prof Cyrus Cooper, Professor of Rheumatology and Director of the MRC Lifecourse Epidemiology Unit at the Universities of Southampton and Oxford. "Physicians should ask their patients, and particularly male patients, about their history of falls after the age of 45. This will not only be valuable information in making an assessment of whether to treat an individual for osteoporosis, but would also give the physician the opportunity to discuss falls prevention strategies."

"Osteoporotic fractures can have debilitating effects on individuals and targeting preventative treatments to those at the highest risk is of great importance." Said Dr Mark Edwards, Academic Clinical Fellow at the MRC Lifecourse Epidemiology Unit, University of Southampton.


Story Source:

The above story is based on materials provided by International Osteoporosis Foundation. Note: Materials may be edited for content and length.


Cite This Page:

International Osteoporosis Foundation. "Inclusion of falls history shown to enhance accuracy of fracture risk assessment models." ScienceDaily. ScienceDaily, 24 March 2011. <www.sciencedaily.com/releases/2011/03/110324153653.htm>.
International Osteoporosis Foundation. (2011, March 24). Inclusion of falls history shown to enhance accuracy of fracture risk assessment models. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2011/03/110324153653.htm
International Osteoporosis Foundation. "Inclusion of falls history shown to enhance accuracy of fracture risk assessment models." ScienceDaily. www.sciencedaily.com/releases/2011/03/110324153653.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins